Stocks
Blueprint Medicines Corporation (BPMC) ROE US GAAP (year values) |
|||||||||
| 2020 | 2021 | 2022 | 2023 | 2024 | LTM ? | CAGR 5 years ? | |||
| ROE, % | ? | 21.4% | -66.4% | -108.3% | -388.2% | -22.5% | -45.5% | ||
| Changes by years, y/y, % | +92pp | -88pp | -42pp | -280pp | +366pp | -20.5% | |||
Blueprint Medicines Corporation. ROE, %
Blueprint Medicines Corporation. ROE, changes, pp
Blueprint Medicines Corporation (BPMC) ROE US GAAP (quarter values) |
||||||||
| 2024Q1 | 2024Q2 | 2024Q3 | 2024Q4 | 2025Q1 | LTM ? | |||
| ROE, % | ? | -92.8% | -64.2% | -40.9% | -22.5% | -45.5% | -45.5% | |
| Changes by years, y/y, % | +47pp | +114pp | +233pp | +366pp | +47pp | |||
| Changes by quarters, q/q, % | +295pp | +29pp | +23pp | +18pp | -23pp | |||
